Assessing Pacira BioSciences (PCRX) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Pacira BioSciences, Inc. (PCRX)
Last pacira biosciences, inc. earnings: 2/20 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacira.com
Company Research
Source: Yahoo! Finance
Recent share performance and business snapshot Pacira BioSciences (PCRX) has been under pressure recently, with the stock showing a 3% decline over the past day and a 5.6% decline over the past week, while still positive over the past month. At a last close of US$21.91, Pacira carries a value score of 2 and reports annual revenue of US$726.41m and net income of US$7.03m. The company has a specialized focus on non opiod pain management products. See our latest analysis for Pacira BioSciences. The 1 day share price return of 3% and 7 day share price return of 5.6% come after a 30 day share price return of 7.51%. The 1 year total shareholder return of 8.9% and 5 year total shareholder return of 68.34% point to fading longer term momentum despite the recent bounce. If Pacira's mixed track record in specialist therapies has you thinking about other healthcare names using advanced tech, it could be worth scanning 27 healthcare AI stocks as a starting list of ideas. With Pacira
Show less
Read more
Impact Snapshot
Event Time:
PCRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PCRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PCRX alerts
High impacting Pacira BioSciences, Inc. news events
Weekly update
A roundup of the hottest topics
PCRX
News
- Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare ConferenceGlobeNewswire
- Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR)GlobeNewswire
- Pacira BioSciences Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Pacira BioSciences, Inc. (PCRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
PCRX
Earnings
- 2/26/26 - Miss
PCRX
Sec Filings
- 2/26/26 - Form S-8
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- PCRX's page on the SEC website